Panacea Index Logo

Command Palette

Search for a command to run...

Wait-and-See Approach or Gluten-Free Diet Administration-The Rational Management of Potential Coeliac Disease.

Nutrients
January 1, 1970
Anna Szaflarska-Popławska
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to evaluate the benefits of a gluten-free diet for patients with potential celiac disease (PCD) and determine its role in preventing progression to full celiac disease (CD).

Results Summary

The study found that patients with clinical gastroenterological or parenteral symptoms often benefit from a gluten-free diet, while those remaining on a gluten-containing diet require close monitoring. The abstract suggests individualized therapeutic decisions due to the heterogeneous nature of PCD.

Population

Patients with potential celiac disease (PCD), particularly those with clinical gastroenterological or parenteral symptoms.

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (1)
InterventionDirectionEndpointPopulationDosageImpactClaim #
gluten-free diet
decrease
clinical gastroenterological or parenteral symptoms
Patients with potential celiac disease
-
often benefit from
#1
Abstract

Potential celiac disease (PCD) is a heterogeneous disease; only some patients develop full celiac disease (CD), characterised by advanced atrophic changes in the small intestine. Few accurate prognostic factors exist for the progression of PCD; therefore, therapeutic decisions should be made on an individual basis in each case. Patients with clinical gastroenterological or parenteral symptoms often benefit from a gluten-free diet, and those left on a diet containing gluten should receive clinical, serological and histopathological supervision.

Medical Subject Headings (MeSH)
Celiac DiseaseClinical Decision-MakingDiet, Gluten-FreeHumans
Study Links
Quality Scores
SafetyNot Assessed
Efficacy70/10
Quality60/10
Citation Metrics
Total Citations3
Citations/Year0.8
Relative Citation Ratio0.30
NIH Percentile16%
Research Impact Scores
APT Score0.50
Weight Score1.29
Normalized Score0.60
Related Supplements